Dipna Pharmachem [DPL] vs Medplus Health [MEDPLUS] Detailed Stock Comparison

Dipna Pharmachem Ltd.

BSE
Loading...

Medplus Health Services Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dipna Pharmachem Ltd. wins in 8 metrics, Medplus Health Services Ltd. wins in 10 metrics, with 0 ties. Medplus Health Services Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dipna Pharmachem Ltd. Medplus Health Services Ltd. Better
P/E Ratio (TTM) 10.09 52.45 Dipna Pharmachem Ltd.
Price-to-Book Ratio 0.35 5.89 Dipna Pharmachem Ltd.
Debt-to-Equity Ratio 23.42 64.69 Dipna Pharmachem Ltd.
PEG Ratio N/A 1.08 N/A
EV/EBITDA 8.55 28.75 Dipna Pharmachem Ltd.
Profit Margin (TTM) 1.92% 3.17% Medplus Health Services Ltd.
Operating Margin (TTM) 2.34% 4.76% Medplus Health Services Ltd.
EBITDA Margin (TTM) 2.34% 4.76% Medplus Health Services Ltd.
Return on Equity 4.24% 8.64% Medplus Health Services Ltd.
Return on Assets (TTM) 1.59% 4.47% Medplus Health Services Ltd.
Free Cash Flow (TTM) $-92.15M $4.81B Medplus Health Services Ltd.
Dividend Yield 23.16% N/A N/A
1-Year Return -67.35% -7.37% Medplus Health Services Ltd.
Price-to-Sales Ratio (TTM) 0.21 1.66 Dipna Pharmachem Ltd.
Enterprise Value $338.55M $113.73B Medplus Health Services Ltd.
EV/Revenue Ratio 0.32 1.74 Dipna Pharmachem Ltd.
Gross Profit Margin (TTM) 44.45% 26.16% Dipna Pharmachem Ltd.
Revenue per Share (TTM) $45 $546 Medplus Health Services Ltd.
Earnings per Share (Diluted) $0.86 $17.28 Medplus Health Services Ltd.
Beta (Stock Volatility) -0.17 0.46 Dipna Pharmachem Ltd.

Dipna Pharmachem Ltd. vs Medplus Health Services Ltd. Stock Performance Analysis

Loading Price Chart...

DPL
MEDPLUS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dipna Pharmachem Ltd.-2.37%-6.80%-16.79%-13.28%-58.32%-59.48%
Medplus Health Services Ltd.-0.53%2.01%3.53%7.18%12.41%11.04%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dipna Pharmachem Ltd.-67.35%-96.95%-96.44%-90.95%-93.55%-93.55%
Medplus Health Services Ltd.-7.37%10.16%-16.81%-16.81%-16.81%-16.81%

Performance & Financial Health Analysis: Dipna Pharmachem Ltd. vs Medplus Health Services Ltd.

MetricDPLMEDPLUS
Market Information
Market Cap i₹228.19M₹108.75B
Market Cap CategorySmall capMid cap
10 Day Avg. Volume i45,900203,009
90 Day Avg. Volume i51,200146,815
Last Close₹6.99₹895.40
52 Week Range₹6.66 - ₹25.66₹732.00 - ₹1,022.20
% from 52W High-72.76%-12.40%
All-Time High₹558.00 (Jan 29, 2024)₹1,343.00 (Jan 17, 2022)
% from All-Time High-98.75%-33.33%
Growth Metrics
Quarterly Revenue Growth-0.20%0.16%
Quarterly Earnings Growth3.19%0.26%
Financial Health
Profit Margin (TTM) i0.02%0.03%
Operating Margin (TTM) i0.02%0.05%
Return on Equity (TTM) i0.04%0.09%
Debt to Equity (MRQ) i23.4264.69
Cash & Liquidity
Book Value per Share (MRQ)₹24.62₹153.91
Cash per Share (MRQ)₹0.29₹41.85
Operating Cash Flow (TTM) i₹-140,640,000₹2.69B
Levered Free Cash Flow (TTM) i₹-160,558,752₹1.50B
Dividends
Last 12-Month Dividend Yield i23.16%N/A
Last 12-Month Dividend i₹5.00N/A

Valuation & Enterprise Metrics Analysis: Dipna Pharmachem Ltd. vs Medplus Health Services Ltd.

MetricDPL (Apr 26, 2026)MEDPLUS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i10.0952.45
Forward P/E iN/A44.24
PEG Ratio iN/A1.08
Price to Sales (TTM) i0.211.66
Price to Book (MRQ) i0.355.89
Market Capitalization
Market Capitalization i₹228.19M₹108.75B
Enterprise Value i₹338.55M₹113.73B
Enterprise Value Metrics
Enterprise to Revenue i0.321.74
Enterprise to EBITDA i8.5528.75
Risk & Other Metrics
Beta i-0.170.46
Book Value per Share (MRQ) i₹24.62₹153.91

Financial Statements Comparison: Dipna Pharmachem Ltd. vs Medplus Health Services Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDPL (2025)MEDPLUS (2025)
Revenue/Sales i1.25B60.87B
Cost of Goods Sold i1.14B46.41B
COGS % of Revenue i91.0%76.2%
Gross Profit i111.90M14.47B
Gross Margin i9.0%23.8%
Research & Development iN/AN/A
Operating Income (EBIT) i40.07M2.39B
Operating Margin i3.2%3.9%
EBITDA i38.19M5.29B
EBITDA Margin i3.1%8.7%
Pre-Tax Income i14.20M1.83B
Pre-Tax Income % of Revenue i1.1%3.0%
Income Tax i4.47M330.56M
Income Tax % of Revenue i0.4%0.5%
Net Income (Profit) i9.73M1.50B
Profit Margin i0.8%2.5%

Balance Sheet & Liquidity Metrics

MetricDPL (2025)MEDPLUS (2025)
Cash & Equivalents i4.26M860.52M
Total Current Assets i1.32B18.44B
Total Current Assets % of Revenue i105.9%30.3%
Total Current Liabilities i849.96M5.77B
Total Current Liabilities % of Revenue i68.0%9.5%
Long-Term Debt i88.90M10.08B
Long-Term Debt % of Revenue i7.1%16.6%
Total Shareholders Equity i384.93M17.40B
Retained Earnings i31.22M4.30B
Retained Earnings % of Revenue i2.5%7.1%
Property, Plant & Equipment i489,00012.49B

Cash Flow Statement Comparison

MetricDPL (2025)MEDPLUS (2025)
Operating Cash Flow i-92.83M2.69B
Operating Cash Flow % of Revenue i-7.4%4.4%
Capital Expenditures i-201,000-584.02M
Free Cash Flow i-92.15M4.81B
FCF Margin i-7.4%7.9%
Debt Repayment i-36.57MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDPLMEDPLUS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i24.05M120.00M
Float Shares i11.37M69.60M
% Held by Insiders i51.68%41.74%
% Held by Institutions i0.00%35.32%
% Held by Public i48.32%22.94%

Dividend Analysis & Yield Comparison: Dipna Pharmachem Ltd. vs Medplus Health Services Ltd.

MetricDPLMEDPLUS
Last 12-Month Dividend i₹5.00N/A
Last 12-Month Dividend Yield i23.16%N/A
3-Year Avg Annual Dividend i₹6.00N/A
3-Year Avg Dividend Yield i1.72%N/A
3-Year Total Dividends i₹18.00N/A
Ex-Dividend DateAug 13, 2024N/A